How to Help Your Patients Find Tyenne in Stock: A Provider's Guide

When a patient is prescribed Tyenne (tocilizumab-aazg), getting them from prescription to first dose can feel like navigating an obstacle course. Prior authorizations, specialty pharmacy routing, insurance step therapy requirements, and patient education all fall partly on the provider's office.

This guide gives your office a practical framework for helping patients get Tyenne quickly and without unnecessary delays.

Step 1: Write the Prescription Correctly From Day One

The prescription itself can impact how quickly the PA process moves. When prescribing Tyenne, include:

Drug name: Tyenne (tocilizumab-aazg) — specify the brand to align with preferred formulary status on most plans

Formulation: IV (for clinic administration) or SC (for home self-injection)

Dose and frequency: e.g., 162 mg SC weekly OR 4–8 mg/kg IV every 4 weeks

Diagnosis code (ICD-10): Specify the qualifying diagnosis clearly (e.g., M05.9 for RA, M31.5 for GCA)

Route to specialty pharmacy: Send electronically to the appropriate specialty pharmacy rather than having the patient carry a paper script

Step 2: Initiate Prior Authorization Proactively

Don't wait for the pharmacy to initiate the PA. Submit the PA at the time of prescription to save 3–7 days. Prepare a complete PA packet in advance:

Clinical notes documenting diagnosis and disease severity (DAS28, clinical assessment)

Prior DMARD treatment history with dates and documentation of inadequate response or intolerance

Baseline labs: CBC, LFTs, TB screening results, lipid panel

Letter of medical necessity if step therapy exceptions are needed (e.g., patient cannot tolerate TNF inhibitors)

Incomplete first submissions are the most common cause of PA delays. Many payers approve Tyenne in 5–10 business days when documentation is complete on the first attempt.

Step 3: Enroll the Patient in KabiCare

Fresenius Kabi's KabiCare hub program provides comprehensive support for both providers and patients. Enroll every new Tyenne patient in KabiCare at the point of prescribing. The program handles:

Benefits investigation — verifying insurance coverage and specialty pharmacy coordination

PA submission and appeals support on behalf of the prescriber's office

Copay card enrollment (eligible commercially insured patients may pay as little as $0)

Patient assistance for uninsured/underinsured patients

Injection training, disease education, and refill reminders

Provider enrollment line: 1-833-522-4227. You can also visit kabicare.us for online enrollment options.

Step 4: Route to the Right Specialty Pharmacy

Choosing the right specialty pharmacy matters. Key considerations:

In-network pharmacies: Always route to a specialty pharmacy in the patient's insurance network to minimize copays. Out-of-network can cost thousands more.

Preferred pharmacies: Some payers (like BCBS of Michigan) require Tyenne SC to route through Walgreens Specialty Pharmacy as part of their preferred arrangement.

Clinical coordination: Choose a specialty pharmacy that will communicate back to your office on order status and any access issues.

Step 5: For IV Patients — Coordinate the Infusion Site

For patients on IV Tyenne, you have additional site-of-care considerations:

In-office infusion: If your practice has an infusion suite, you can administer Tyenne IV directly. The drug is ordered through your practice's specialty drug supplier.

Hospital-affiliated infusion center: Billed under the patient's medical benefit (typically Part B for Medicare patients). Pre-authorize the site of care as well as the drug.

Home infusion: Some payers approve home infusion through specialized home infusion companies. Costs can be lower for patients, but requires additional clinical oversight arrangements.

Using medfinder to Help Patients Find Pharmacies

When patients report that their specialty pharmacy is delayed or out of stock, medfinder for providers can help. medfinder contacts pharmacies in the patient's area to find which ones can fill the prescription — removing the burden from your office staff and your patients alike.

For more context on the broader Tyenne availability landscape, see our provider-focused overview: What providers need to know about Tyenne in 2026.